Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 9/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1829558 | 0.85 | MAPT (0.48) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL9755832 | 0.83 | CYP2C19 (0.48) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL1028846 | 0.82 | KMT2A (0.44) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL9971684 | 0.81 | CYP2C19 (0.43) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL4378855 | 0.81 | CYP1A2 (0.50) | CYP2C19HIF1AMAPTKMT2ACYP1A2 | |
| SCHEMBL4375323 | 0.79 | CYP2C19 (0.49) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL28779828 | 0.78 | KIF11 (0.43) | CYP2C19HIF1AKIF11KMT2ACYP1A2 | |
| SCHEMBL8909445 | 0.78 | CYP2C19 (0.40) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL8909447 | 0.78 | CYP2C19 (0.40) | CYP2C19HIF1AKIF11MAPTKMT2A | |
| SCHEMBL8854204 | 0.75 | MAPT (0.48) | CYP2C19HIF1AKIF11MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116940466-A | Consumer products | 联合利华知识产权控股有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-109311789-B | Process for preparing 2, 3-unsaturated alcohols | 巴斯夫欧洲公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-112469807-B | Benefit agent delivery particles | 联合利华知识产权控股有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-109310974-B | Process for preparing microcapsules | 西姆莱斯股份公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-111770982-B | Laundry detergent | 联合利华知识产权控股有限公司 | 2022-05-27 | — | — | CN | disclosed |
| CN-113544250-A | Composition comprising a metal oxide and a metal oxide | 联合利华知识产权控股有限公司 | 2021-10-22 | — | — | CN | disclosed |
| CN-111615551-B | Laundry detergent | 联合利华知识产权控股有限公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-113242750-A | Microcapsules | 西姆莱斯股份公司 | 2021-08-10 | — | — | CN | disclosed |
| CN-108367088-B | Composition and delivery system and filling for spraying two or more compositions | 约翰逊父子公司 | 2021-07-06 | — | — | CN | disclosed |
| CN-108473484-B | Compounds useful as TRPM8 modulators | 弗门尼舍公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-111770982-A | Laundry detergent | 荷兰联合利华有限公司 | 2020-10-13 | — | — | CN | disclosed |
| CN-111615551-A | Laundry detergent | 荷兰联合利华有限公司 | 2020-09-01 | — | — | CN | disclosed |
| CN-107072900-B | High coverage, low odor malodor counteracting compounds and methods of use | 国际香料和香精公司 | 2020-03-20 | — | — | CN | disclosed |
| CN-105722495-B | Polyurea or polyurethane capsules | 国际香料和香精公司 | 2020-02-28 | — | — | CN | disclosed |
| CN-102753522-B | Substituted pyrrolidine-2-carboxamides | HOFFMANN LA ROCHE | 2013-11-27 | — | — | CN | disclosed |
| US-7626023-B2 | Compounds for treating tumors | WYETH (US) | 2009-12-01 | — | — | US | disclosed |
| US-20080221181-A1 | COMPOUNDS FOR TREATING TUMORS | WYETH HOLDINGS CORPORATION (US) | 2008-09-11 | — | — | US | disclosed |
| US-7390910-B2 | Compounds for treating tumors | WYETH (US) | 2008-06-24 | — | — | US | disclosed |
| WO-2005016958-A2 | COMPOUNDS FOR TREATING TUMORS | WYETH HOLDINGS CORPORATION (US) | 2005-02-24 | — | — | WO | disclosed |
| US-20050037977-A1 | Compounds for treating tumors | WYETH HOLDINGS CORPORATION (US) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221181-A1 | COMPOUNDS FOR TREATING TUMORS | RB1, MRPL9, BCOR | CYP2C19 2819/4885HIF1A 1664/4885KIF11 1677/4885 |
| US-20050037977-A1 | Compounds for treating tumors | RB1, MRPL9, BCOR | CYP2C19 2819/4885HIF1A 1664/4885KIF11 1677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.